AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced, on June 15, 2018, that it has entered into a definitive agreement to divest Cord Blood Registry (CBR®) to GI Partners, a private equity investment firm, for $530 million in an all cash sale. The parties expect to close the transaction in the third quarter of 2018.
GI Partners will also simultaneously acquire California Cryobank (CCB), the world’s premier donor sperm and egg bank in a combined transaction.
Allergy sufferers who experience anaphylaxis—an acute, life-threatening allergic reaction requiring urgent treatment—may soon have a new delivery option for receiving a timely dose of epinephrine to avoid a potentially fatal outcome.
U.S.-based camera company Photometrics and German-based software company arivis, have teamed up to provide imaging and big data handling solutions to researchers to streamline their science. This partnership provides new imaging technology and software to produce more detailed data while handling those data efficiently. Photometrics is headquartered in Tucson, Arizona. Arivis, Inc., the U.S. subsidiary of arivis, is based in Phoenix, Arizona.
Company targets accelerated diagnosis and treatment of cancer by providing optimal tissue samples for effective personalized medicine
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced a distribution agreement with Bug Off Pest Control Center (“Bug Off”) for ContraPest®. In addition to distribution, Bug Off will be marketing and selling ContraPest throughout its network, and providing ongoing training to pest management professionals (PMPs) in the Greater New York area.